Short-Term Debt to Equity Ratio: AC Immune (ACIU)
The stable R&D core of AC Immune (ACIU) is supported by options and alliances with industry behemoths, which prevents talent attrition. The business relies on a closed precision medicine system, where unique vaccine development methods create significant switching costs for clients. The current market quotes visualized below, with the 0.04 metric, complement data on automated AI synthesis of Alzheimer's drugs requiring medical supervision.
Analytical breakdowns for AC Immune
- stock quotes and analyst forecast:
- company stock exchange capitalization indicators:
- issuer book value statistics:
- company liabilities and liquidity data:
- company profitability and valuation multiples indicators:
Fundamental company analysis:AC Immune Corp ACIU
Monitoring short-term debt load is critical for capital protection amid uncertainty. This ratio compares obligations maturing within one year against total equity to measure liquidity risk. By analyzing the trend of short-term liabilities relative to equity, an investor assesses a firm's financial stability. For AC Immune (ACIU), this balance determines the ability to fund costly neurotherapy clinical trials without the urgent need for borrowed funds.
Direct competitors
Short-Term Debt to Capital BIIB|NBIX - Current Liabilities to Capital|Regencell Bioscience - Short-Term Debt to Equity Ratio|Short-Term Debt to Capital axsome.com AXSM|ACAD - Short-Term Debt to Equity|Ratio of Short-Term Indebtedness to Capital XENE (Xenon Pharmaceuticals Inc.)|Viking Pharma (VKTX) - Short-Term Debt to Equity|Current Liabilities to Capital Supernus Corp (SUPN)|CPRX (Catalyst Pharmaceuticals) - Short-Term Debt to Capital|Short-Term Debt to Capital denalitherapeutics.com|Short-Term Debt to Capital HRMY|Short-Term Debt to Equity Ratio Biohaven Ltd BHVN|Amylyx - Short-Term Debt to Equity Ratio|Ratio of Short-Term Indebtedness to Capital TRVI|Praxis Precision Medicines - Short-Term Debt to Capital|Short-Term Debt to Capital Coefficient anavex.com AVXL|CeriBell (CBLL) - Short-Term Debt to Equity|Short-Term Debt to Equity Ratio Prothena Biosciences|Short-Term Debt to Equity Alector Inc.|Short-Term Debt to Equity Ratio Annexon Biosciences Inc. (ANNX)|Short-Term Debt to Equity Ratio OMER (Omeros Corporation)|Short-Term Debt to Capital neurogene.com (NGNE)|Short-Term Debt to Equity Voyager Therapeutics, Inc. VYGR|NMRA: Short-Term Debt to Capital Ratio|Scilex Holding Co. - Short-Term Debt to Capital|Current Liabilities to Capital Tevogen Bio Inc.|ACOG: Short-Term Debt to Capital|cogrx.com (CGTX) - Short-Term Debt to Capital|IKT (Inhibikase Therapeutics, Inc.) - Short-Term Debt to Capital|Short-Term Debt to Equity Ratio Cassava Sciences Inc (SAVA)|Short-Term Debt to Capital ASRT|Short-Term Debt to Capital Coefficient coyatherapeutics.com|Vistagen - Short-Term Debt to Equity Ratio|Short-Term Debt to Capital Ovid Therapeutics Inc OVID|ABOS - Short-Term Debt to Equity|CRVO (CervoMed, Inc.) - Short-Term Debt to Capital Ratio|ATHE: Short-Term Debt to Capital|Current Liabilities to Capital Clene (CLNN)|Short-Term Debt to Equity Ratio PEPG|Short-Term Debt to Capital jupiterneurosciences.com|Short-Term Debt to Equity Relmada Therapeutics, Inc. (RLMD)|ANVS (Annovis Bio Inc) - Ratio of Short-Term Indebtedness to Capital|Short-Term Debt to Equity Grace Therapeutics GRCE|Firefly Neuro (AIFF) - Current Liabilities to Capital|ANEW Medical, Inc. - Short-Term Debt to Capital|NRSN - Short-Term Debt to Capital|RVPH: Short-Term Debt to Capital|Short-Term Debt to Equity Ratio MetaVia|Short-Term Debt to Equity Ratio NRXS|HSDT: Ratio of Short-Term Indebtedness to Capital|Short-Term Debt to Capital PASG|Short-Term Debt to Capital Coefficient bionomics.com.au|Short-Term Debt to Equity Minerva Neurosciences, Inc. NERV|ATHA - Short-Term Debt to Equity Ratio|ADXN - Short-Term Debt to Equity|Alzamend Neuro, Inc. (ALZN) - Short-Term Debt to Equity Ratio|CYCN (cyclerion.com) - Short-Term Debt to Equity Ratio|Protagenic Therapeutics, Inc. (PTIX) - Short-Term Debt to Capital|Short-Term Debt to Equity Pasithea Therapeutics Corp|Short-Term Debt to Capital Ratio CRGT (Cortigent Medical)|Short-Term Debt to Capital ATXI|BCLI - Current Liabilities to Capital|Short-Term Debt to Capital CARA (Cara Therapeutics, Inc.)|Short-Term Debt to Capital chromocell.com CHRO|Eliem - Short-Term Debt to Capital|Intra-Cellular Therapies (ITCI) - Short-Term Debt to Equity Ratio|LBPH: Short-Term Debt to Capital|MRNS - Short-Term Debt to Capital Coefficient|Short-Term Debt to Equity Ratio NKGN|Short-Term Debt to Capital neurobopharma.com|Short-Term Debt to Equity Sage Therapeutics (SAGE)|Synaptogenix Inc. - Short-Term Debt to Capital Ratio|Short-Term Debt to Capital TRVN (Trevena, Inc)|Vigil Neuroscience Inc. (VIGL) - Current Liabilities to Capital|WENA: Short-Term Debt to Equity Ratio|CERE - Short-Term Debt to Capital